Tim Sangster was appointed to the position of Executive Director at Celerion’s Lincoln, Nebraska facility in August 2020. Mr. Sangster was most recently the European Head of Chromatographic Bioanalysis for Charles River Laboratories, a nonclinical contract research organization (CRO) based in the United Kingdom with facilities in sixteen countries. Additionally, Tim has prior experience from Huntingdon Life Sciences, a British nonclinical CRO, and pharma company AstraZeneca.
.svg)
